pneumonia
cap
remain
major
caus
hospit
death
among
children
year
age
due
signific
public
health
social
economi
effect
measur
need
control
real
role
respiratori
virus
pathogenesi
cap
remain
debat
concern
especi
human
bocaviru
mostli
detect
respiratori
virus
often
detect
asymptomat
sinc
discoveri
found
nasopharyng
aspir
sampl
npa
hospit
children
lower
respiratori
howev
shown
persist
week
even
month
acut
infect
detect
low
viral
load
npa
question
clinic
valu
shown
measur
igm
igg
antibodi
possibl
diagnos
acut
infect
children
hospit
acut
sever
respiratori
current
studi
use
specif
serolog
assess
frequenc
acut
infect
children
cap
detect
pcr
nasopharyng
mucu
prospect
studi
conduct
feder
univers
bahia
hospit
salvador
northeast
brazil
clinic
trial
use
amoxicillin
http
clinicaltrialsgov
identifi
novemb
april
case
children
age
month
cap
came
pediatr
emerg
depart
cap
diagnos
pediatrician
duti
diagnosi
base
respiratori
complaint
cough
difficulti
breath
associ
lower
respiratori
patholog
find
plu
presenc
pulmonari
infiltr
consolid
chest
radiograph
cxr
frontal
later
view
taken
admiss
read
pediatrician
duti
cap
case
identifi
cap
case
present
follow
find
lower
chest
indraw
inabl
drink
seizur
somnol
central
cyanosi
grunt
calm
child
nasal
flare
world
health
organ
criteria
sever
cap
exclus
criteria
chronic
debilit
diseas
anatom
abnorm
respiratori
tract
cancer
chronic
pulmonari
ill
besid
asthma
immunolog
defect
progress
neurolog
disord
psychomotor
retard
heart
diseas
clinic
repercuss
hemoglobinopathi
liver
kidney
diseas
sever
malnutrit
concurr
infect
mother
hospit
previou
day
amoxicillin
antibiot
use
last
h
allergi
amoxicillin
histori
aspir
primari
result
trial
assess
respiratori
viru
detect
secondari
object
clinic
trial
enrol
written
inform
consent
obtain
parentsleg
guardian
everi
patient
evalu
train
medic
student
supervis
senior
pediatrician
research
team
complet
physic
examin
perform
data
demograph
clinic
histori
physic
examin
record
form
follow
variabl
age
sex
diseas
durat
complaint
cough
fever
difficulti
breath
wheez
vomit
axillari
temperatur
respiratori
rate
rr
weight
find
physic
examin
chest
retract
reduc
pulmonari
expans
rhonchi
wheez
crackl
visit
schedul
occur
week
recruit
fever
defin
axillari
temperatur
tachypnea
rr
breathsmin
children
age
month
rr
breathsmin
children
month
nutrit
evalu
perform
use
softwar
anthro
version
centr
diseas
control
prevent
malnutrit
sever
malnutrit
defin
index
respect
use
nation
centr
health
statist
npa
acut
serum
sampl
collect
patient
upon
admiss
convalesc
serum
sampl
collect
visit
npa
aspir
nostril
dispos
mucu
extractor
insert
nasopharynx
sampl
immedi
place
identifi
empti
tube
frozen
feder
univers
bahia
hospit
laboratori
pend
shipment
research
laboratori
data
collect
finish
npa
sampl
sent
univers
turku
depart
clinic
virolog
turku
finland
wherea
pair
serum
sampl
sent
univers
helsinki
depart
virolog
helsinki
finland
airplan
maintain
thaw
nucleic
acid
extract
multiplex
pcr
test
kit
anyplex
tm
ii
seegen
seoul
south
korea
use
detect
human
adenoviru
hadv
influenza
flu
b
flu
b
virus
parainfluenza
viru
type
piv
piv
piv
piv
rhinoviru
rv
respiratori
syncyti
virus
rsv
b
rsv
b
coronavirus
hcov
hcov
hcov
metapneumoviru
hmpv
enterovirus
ev
npa
anyplex
tm
ii
detect
kit
multiplex
pcr
assay
base
tag
oligonucleotid
cleavag
extens
addit
pcr
test
use
detect
ev
rv
npa
sampl
previous
due
known
long
persist
airway
specif
igm
igg
measur
pair
serum
sampl
patient
diagnost
criteria
acut
primari
infect
presenc
one
follow
marker
presenc
igm
fourfold
greater
increas
convers
igg
pair
sera
hbov
igg
igm
enzym
immunoassay
eia
describ
recombin
particl
use
antigen
two
eia
antibodi
block
cutoff
absorb
valu
antibodi
presenc
mean
sd
competit
igg
borderlin
result
eia
consid
indetermin
pcr
methodolog
highli
vulner
possibl
fals
posit
result
due
contamin
reagent
specimen
pcr
amplicon
analys
perform
accredit
clinic
viru
diagnost
laboratori
present
work
rigor
measur
taken
throughout
whole
studi
avoid
amplicon
well
contamin
sampl
size
estim
case
detect
npa
consid
expect
frequenc
acut
serolog
diagnos
infect
equal
total
width
confid
interv
ci
ci
perform
bivari
analysi
frequenc
clinic
characterist
children
without
acut
infect
compar
use
fisher
exact
test
appropri
continu
variabl
present
median
interquartil
rang
iqr
assess
use
u
test
due
distribut
test
signific
frequenc
miss
inform
low
chose
handl
absent
data
exclud
case
laboratori
procedur
perform
train
personnel
blind
clinic
data
analys
perform
use
statist
packag
social
scienc
spss
version
studi
conduct
accord
declar
helsinki
nation
institut
standard
approv
ethic
committe
feder
univers
bahia
approv
refer
number
total
children
enrol
clinic
trial
children
npa
acut
convalesc
serum
sampl
collect
includ
studi
median
iqr
interv
collect
acut
convalesc
sampl
day
tabl
present
baselin
characterist
studi
case
npa
sampl
test
virus
virus
detect
sampl
ci
found
ci
case
case
acut
recent
infect
confirm
serolog
case
ci
overal
acut
recent
infect
confirm
case
viru
detect
ci
multipl
virus
detect
among
found
convers
case
sole
viru
detect
detect
p
acut
infect
serolog
diagnos
case
least
one
viru
compar
case
sole
viru
detect
p
among
case
acut
infect
multipl
viru
detect
case
viru
detect
case
virus
detect
case
virus
detect
case
virus
detect
case
virus
detect
alongsid
respiratori
virus
concomitantli
found
figur
demonstr
frequenc
respiratori
viru
found
among
case
rhinoviru
frequent
found
viru
detect
case
wherea
neither
flu
piv
detect
tabl
also
show
comparison
case
without
acut
infect
signific
differ
found
children
acut
sole
infect
compar
children
acut
multipl
viru
detect
tabl
figur
present
monthli
distribut
case
acut
infect
diagnos
serolog
case
detect
npa
recruit
cap
case
month
studi
period
studi
found
children
cap
nasopharynx
one
quarter
show
serolog
evid
acut
recent
infect
three
quarter
detect
children
cap
associ
current
infect
probabl
due
prolong
shed
previou
infect
agreement
mani
earlier
studi
detect
major
case
togeth
respiratori
virus
importantli
one
fifth
children
multipl
viral
detect
acut
infect
show
coinfect
alway
innoc
bystand
use
serodiagnosi
clearli
shown
year
age
children
infect
origin
serodiagnosi
studi
kantola
et
al
children
acut
wheez
exhibit
igm
antibodi
andor
increas
igg
antibodi
et
found
children
cap
serolog
evid
acut
infect
seven
patient
hospit
member
research
team
previous
studi
serolog
infect
children
hospit
due
strict
criteria
cap
patient
evid
acut
infect
observ
other
strongli
suggest
caus
agent
childhood
cap
furthermor
observ
suggest
half
acut
infect
cap
case
ill
clinic
thu
necessit
hospit
wide
use
multiplex
pcr
test
greatli
increas
understand
role
respiratori
virus
pneumonia
mani
studi
children
cap
respiratori
virus
detect
howev
mani
virus
includ
detect
similar
higher
rate
asymptomat
control
question
whether
virus
caus
agent
concept
debat
respiratori
virus
may
also
caus
asymptomat
infect
explain
detect
virus
asymptomat
recent
serolog
made
import
contribut
question
studi
zhang
et
al
children
cap
serolog
mostli
agre
serolog
rsv
hmpv
piv
hadv
increas
diagnost
yield
rang
interestingli
acut
infect
respiratori
viru
prolong
viral
shed
last
longer
serolog
markedli
decreas
yield
diagnos
compar
pcr
nasopharyng
mucu
note
acut
infect
report
one
studi
none
asymptomat
children
splice
mrna
nasopharyng
mucu
suggest
virus
detect
clinic
role
multipl
respiratori
viru
detect
pathogenesi
childhood
cap
fulli
understood
recent
publish
report
conclud
associ
multipl
respiratori
viru
detect
diseas
studi
multipl
virus
detect
approxim
case
cap
studi
suggest
might
pathogen
role
children
cap
also
multipl
viru
detect
case
randomli
found
among
month
year
studi
figur
among
lebanes
children
hospit
either
bronchiol
cap
found
airway
sampl
season
except
may
explain
differ
weather
condit
year
countri
lebanon
mild
weather
allow
occurr
signific
temperatur
climat
chang
brazil
tropic
countri
steadi
climat
condit
throughout
year
studi
certain
limit
studi
singl
center
studi
limit
wider
gener
observ
due
econom
restrict
serolog
studi
patient
probabl
also
studi
cap
children
would
increas
diagnost
yield
studi
acut
wheez
children
test
neg
nasopharynx
show
serolog
evid
acut
furthermor
studi
copi
number
dna
serum
howev
previous
shown
finnish
studi
children
pcr
posit
acut
infect
diagnos
serolog
wherea
posit
pcr
serolog
therefor
serolog
enough
show
reliabl
actual
acut
infect
moreov
recent
publish
compar
serolog
dna
pcr
high
clinic
sensit
viral
persist
low
specif
addit
limit
analyz
strength
studi
includ
long
recruit
period
last
almost
four
half
year
reduc
risk
bia
regard
viral
season
high
number
cap
patient
addit
serolog
studi
carri
laboratori
virolog
recogn
serolog
accur
method
diagnos
acut
infect
even
compar
detect
messeng
rna
impli
viral
conclus
observ
provid
support
causal
role
pathogenesi
childhood
cap
sole
agent
respiratori
virus
none
declar
author
